Advertisement
Screener

NEUROPATHIX, INC. Patents: Applications Pending

NEUROPATHIX, INC. Patent Applications Pending

2 applications still open at the USPTO, newest filing first, as the USPTO Open Data Portal records them; the company is the first-named applicant. The application number opens the full record at Patent Center.

  • 2021-02-01: Application 63144471; Invention FUNCTIONALIZED 1,3-BENZENE DIOLS AND THEIR METHOD OF USE FOR THE TREATMENT OF INFLAMMATION AND PAIN; Applicant Neuropathix, Inc.; Status Provisional Application Expired.
  • 2015-01-09: Application PCTUS2015010827; Invention NOVEL FUNCTIONALIZED 1,3-BENZENE DIOLS AND THEIR METHOD OF USE FOR THE TREATMENT OF HEPATIC ENCEPHALOPATHY; Applicant KANNALIFE, INC.; Status RO PROCESSING COMPLETED-PLACED IN STORAGE.
FiledApplicationInventionApplicantStatusPublished asInventor nameInventor countryExaminer
2021-02-0163144471FUNCTIONALIZED 1,3-BENZENE DIOLS AND THEIR METHOD OF USE FOR THE TREATMENT OF INFLAMMATION AND PAINNeuropathix, Inc.Provisional Application Expired
Douglas BRENNEMAN
William A. KINNEY
Mark E. MCDONNELL
Dean PETKANAS
United States
United States
United States
United States
2015-01-09PCTUS2015010827NOVEL FUNCTIONALIZED 1,3-BENZENE DIOLS AND THEIR METHOD OF USE FOR THE TREATMENT OF HEPATIC ENCEPHALOPATHYKANNALIFE, INC.RO PROCESSING COMPLETED-PLACED IN STORAGE
DOUGLAS E. BRENNEMAN
DEAN PETKANAS
MARK MCDONNELL
WILLIAM ALVIN KINNEY
United States
United States
United States
United States
THOMAS, SHANE M